CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML

Clinical trial NCT02944162 · UNKNOWN

Trial details

NCT number: NCT02944162
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia With Maturation Acute Myeloid Leukemia Without Maturation ANLL

Start date: 2016-10-01
Primary completion: 2017-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.